Navigation Links
Tug of war in the cells
Date:3/19/2008

This release is available in German.

Transport processes in the cells of our body resemble the transport of goods on the roads. Molecular motors, which are special protein molecules, act as trucks. They carry the cellular cargo on piggy-back and transport it along microtubules, which are the roads of the cell. However, the molecular transporters are a billion times smaller than trucks and can only move as far as the beginning or end of the microtubule, depending on their type. They have to fight their way through a crowd that is more like a busy pedestrian area than a motorway, and also have to compete with motors that want to move in the opposite direction, as scientists at the Max Planck Institute of Colloids and Interfaces in Potsdam have now discovered in a computer simulation.

Several motors are always involved in the tug-of-war over a cargo - for example, some of the kinesin type and some of the dynein type. The kinesin motors move to the end of the microtubule that biologists call the positive end, while the dynein motors move to the minus end. The findings of the Potsdam-based scientists show that the stronger motor team determines the direction in which the cargo is moved. It involves a tug-of-war where opposing motors break off from the microtubule. It was previously assumed that there was a system of coordination that allowed for only one team of motors; it was believed this alternated between one team and the other.

"The tug-of-war is the simplest imaginable mechanism," says Melanie Mueller, one of the scientists involved in the project. "But it is possible, if you consider the properties of the individual motors measured experimentally. They produce a strong non-linear reaction when they are pulled." A motor from the losing team is subject to a strong force and is quickly removed from the microtubule. The remaining motor
'/>"/>

Contact: Melanie J.I. Mueller
mmueller@mpikg.mpg.de
49-331-567-9623
Max-Planck-Gesellschaft
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Scientists successfully awaken sleeping stem cells
2. How is H pylori adhesion to gastric cells associated with MUC1 mucin VNTR size?
3. Post brain injury: New nerve cells originate from neural stem cells
4. Blood Stem Cells Originate in the Placenta
5. Einstein researchers genetically engineer immune cells into potent weapons for battling HIV
6. Fugitive cancer cells can be blocked by stopping blood cells that aid them
7. Cell recycling protects tumor cells from anti-cancer therapy
8. UCLA researchers find blood stem cells originate and are nurtured in the placenta
9. Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
10. Greatest Satisfaction Preserving Granddaughters Cord Blood Stem Cells
11. Neural progenitor cells as reservoirs for HIV in the brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tug of war in the cells
Tug of war in the cells
Breaking Medicine Technology:$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5High Blood Pressure Medicines Show Promise For Treating Heart Disease 5576 1High Blood Pressure Medicines Show Promise For Treating Heart Disease 5576 2High Blood Pressure Medicines Show Promise For Treating Heart Disease 5576 3As Greenland melts 10423 1As Greenland melts 10423 2Research with wood ducks earns graduate student 2 national awards 10420 1
Other Medicine Technology:Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 2Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 3Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 2Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 3Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 5Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 6Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 7Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 8Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 9